Rare pancreatic cancer treatment.
“Results from a late-stage Pfizer trial studying the effectiveness of Sutent in stemming the advancement of a rare pancreatic cancer were so encouraging that the company called it quits and extended the treatment to placebo-popping patients.” This from Forbes just now. Wouldn’t it be nice if Steve Jobs’ cancer .....[ Edited: 22 February 2012 02:01 PM by Laurie Fleming ]
Hocus pokus, hope it don’t poke us in the eye.
I think he’s past that stage, or at least so we’ve been led to believe. His current problem has to do with nourishing his body properly.